San Diego, CA, United States of America

Jagadis Sankaranarayanan


Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Jagadis Sankaranarayanan: Innovator in Nanocarrier Technology

Introduction

Jagadis Sankaranarayanan is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of nanotechnology, particularly in the development of innovative nanocarriers. With a total of 4 patents, his work focuses on enhancing the delivery of therapeutic payloads within biological systems.

Latest Patents

Sankaranarayanan's latest patents include groundbreaking inventions such as "Nanocarriers with multi-photon response elements." This invention involves compositions where dendrimers and/or nanoparticles are synthesized with multi-photon responsive elements and self-immolative oligomers. These compositions can selectively deliver payloads within tissue by utilizing irradiation, thereby amplifying sensitivity to irradiation. Another notable patent is "Polymeric nanocarriers with linear dual response mechanism." This invention features nanocarriers synthesized with polymers that respond to lower pH and/or reactive oxygen species (ROS) by degrading. These compositions are designed to selectively deliver payloads within patients by responding to specific local conditions.

Career Highlights

Sankaranarayanan is affiliated with the University of California, where he continues to advance research in nanotechnology. His innovative approaches have positioned him as a key figure in the development of effective drug delivery systems.

Collaborations

He has collaborated with notable researchers such as Adah Almutairi and Nadezda Fomina, contributing to the advancement of nanocarrier technology.

Conclusion

Jagadis Sankaranarayanan's work in nanocarrier technology exemplifies the potential of innovative solutions in medicine. His patents reflect a commitment to improving therapeutic delivery systems, which could significantly impact patient care in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…